TABLE 3.
Inhibition of HPV-16-GFP PsV infection of cervical cancer-derived cell lines by SB105-A10
| Cell line | % Inhibition by SB105-A10a | CC50 (μg/ml) |
|---|---|---|
| 293TTb | 97 | >100 |
| SiHa | 89 | >100 |
| HeLa | 86 | >100 |
| C33A | 94 | >100 |
A fixed dose of 30 mg/ml was used.
293TT is not a cervical cancer-derived cell line but is shown here as a control.